Published in Med J Aust on July 18, 2011
Prescribing for people in custody. Aust Prescr (2015) 1.47
Paying the price: the pressing need for quality, cost, and outcomes data to improve correctional health care for older prisoners. J Am Geriatr Soc (2013) 0.90
Sensitivity of a national coronial database for monitoring unnatural deaths among ex-prisoners in Australia. BMC Res Notes (2011) 0.79
Patient outcomes following discharge from secure psychiatric hospitals: systematic review and meta-analysis. Br J Psychiatry (2016) 0.78
Why are prisoners dying after they're released? Med J Aust (2011) 0.75
Counting the cost: estimating the number of deaths among recently released prisoners in Australia. Med J Aust (2011) 0.75
Development and Validation of a National System for Routine Monitoring of Mortality in People Recently Released from Prison. PLoS One (2016) 0.75
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. Lancet (2008) 8.73
Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis (2011) 7.41
Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. J Infect Dis (2008) 6.73
Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study. AIDS (2003) 5.61
Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77
Meta-analysis of drug-related deaths soon after release from prison. Addiction (2010) 3.96
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes. Lancet (2004) 3.59
Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study. AIDS (2010) 3.47
Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study. J Infect Dis (2010) 3.30
Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART. AIDS (2010) 2.65
No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial. Lancet (2004) 2.43
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. AIDS (2008) 2.27
Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase. AIDS (2007) 2.27
Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells. Nat Med (2009) 2.21
Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. Drug Alcohol Depend (2009) 2.20
How effective is in vitro fertilization, and how can it be improved? Fertil Steril (2011) 2.10
Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study. BMJ (2009) 2.10
Diabetic retinopathy management by Australian optometrists. Clin Experiment Ophthalmol (2011) 2.02
Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial. JAMA (2002) 1.88
Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration. J Acquir Immune Defic Syndr (2013) 1.82
Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use. Clin Infect Dis (2012) 1.74
High-cost users of hospital beds in Western Australia: a population-based record linkage study. Med J Aust (2006) 1.72
Estimation of risk of cancers before occurrence of acquired immunodeficiency syndrome in persons infected with human immunodeficiency virus. Am J Epidemiol (2002) 1.60
The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology. Epidemiology (2011) 1.59
A randomized controlled trial of a smoking cessation intervention conducted among prisoners. Addiction (2013) 1.51
Repeat adverse drug reactions causing hospitalization in older Australians: a population-based longitudinal study 1980-2003. Br J Clin Pharmacol (2007) 1.50
Implementation and Operational Research: Risk Charts to Guide Targeted HIV-1 Viral Load Monitoring of ART: Development and Validation in Patients From Resource-Limited Settings. J Acquir Immune Defic Syndr (2015) 1.48
Mortality rates among nuclear industry workers at Lucas Heights Science and Technology Centre. Aust N Z J Public Health (2005) 1.45
Changes in hematologic parameters and efficacy of thymidine analogue-based, highly active antiretroviral therapy: a meta-analysis of six prospective, randomized, comparative studies. Clin Ther (2004) 1.43
Traumatic brain injury rates and sequelae: a comparison of prisoners with a matched community sample in Australia. Brain Inj (2010) 1.42
Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy. Sex Transm Infect (2012) 1.41
Where there's smoke, there's fire: high prevalence of smoking among some sub-populations and recommendations for intervention. Drug Alcohol Rev (2006) 1.28
Mental illness related disparities in diabetes prevalence, quality of care and outcomes: a population-based longitudinal study. BMC Med (2011) 1.28
The impact of co-payment increases on dispensings of government-subsidised medicines in Australia. Pharmacoepidemiol Drug Saf (2008) 1.27
Antiretroviral therapy outcomes of HIV-infected children in the TREAT Asia pediatric HIV observational database. J Acquir Immune Defic Syndr (2010) 1.25
Epidemiology of hepatitis C virus infection in Australia. J Clin Virol (2003) 1.25
Trends in anal cancer in Australia, 1982-2005. Vaccine (2011) 1.24
Survival of HIV-infected children: a cohort study from the Asia-Pacific region. J Acquir Immune Defic Syndr (2011) 1.24
Development of appropriate coronary heart disease risk prediction models in HIV-infected patients. Circulation (2008) 1.24
Is severe liver disease a common outcome for people with chronic hepatitis C? J Gastroenterol Hepatol (2002) 1.22
Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy. AIDS (2009) 1.22
The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study. Addiction (2014) 1.20
Trends in antiretroviral treatment use and treatment response in three Australian states in the first decade of combination antiretroviral treatment. Sex Health (2008) 1.18
Reproducibility of adenosine stress cardiovascular magnetic resonance in multi-vessel symptomatic coronary artery disease. J Cardiovasc Magn Reson (2010) 1.16
Estimates of chronic hepatitis B virus infection in Australia, 2000. Aust N Z J Public Health (2004) 1.15
Promoting smoking cessation among prisoners: feasibility of a multi-component intervention. Aust N Z J Public Health (2006) 1.15
A multipurpose comorbidity scoring system performed better than the Charlson index. J Clin Epidemiol (2005) 1.14
Characterizing trends in HIV infection among men who have sex with men in Australia by birth cohorts: results from a modified back-projection method. J Int AIDS Soc (2009) 1.13
Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease. Nephrol Dial Transplant (2011) 1.12
Whole population trends in complications of cataract surgery over 22 years in Western Australia. Ophthalmology (2011) 1.11
Serum macrophage inhibitory cytokine-1 (MIC-1/GDF15): a potential screening tool for the prevention of colon cancer? Cancer Epidemiol Biomarkers Prev (2011) 1.11
Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: implications for prevention policy and planning. Addiction (2009) 1.10
The influence of Pavlovian cues on instrumental performance is mediated by CaMKII activity in the striatum. Eur J Neurosci (2007) 1.10
Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America. J Int AIDS Soc (2012) 1.10
Has the true prevalence of voiding difficulty in urogynecology patients been underestimated? Int Urogynecol J Pelvic Floor Dysfunct (2006) 1.10
Smoking and its correlates in an Australian prisoner population. Drug Alcohol Rev (2006) 1.09
Randomized, open-label, comparative trial to evaluate the efficacy and safety of three antiretroviral drug combinations including two nucleoside analogues and nevirapine for previously untreated HIV-1 Infection: the OzCombo 2 study. HIV Clin Trials (2002) 1.09
Age- and sex-specific trends in the incidence of hospitalized acute coronary syndromes in Western Australia. Circ Cardiovasc Qual Outcomes (2011) 1.09
Modelling the hepatitis C virus epidemic in Australia. Drug Alcohol Depend (2007) 1.08
The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection: final results from a randomized clinical trial (Pulse). J Acquir Immune Defic Syndr (2006) 1.08
Pediatric HIV clinical care resources and management practices in Asia: a regional survey of the TREAT Asia pediatric network. AIDS Patient Care STDS (2010) 1.07
Changes in mortality following HIV and AIDS and estimation of the number of people living with diagnosed HIV/AIDS in Australia, 1981-2003. Sex Health (2009) 1.06
Increase in caesarean deliveries after the Australian Private Health Insurance Incentive policy reforms. PLoS One (2012) 1.06
Regular primary care lowers hospitalisation risk and mortality in seniors with chronic respiratory diseases. J Gen Intern Med (2010) 1.06
TREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratories. J Virol Methods (2009) 1.06
Do condoms cause rape and mayhem? The long-term effects of condoms in New South Wales' prisons. Sex Transm Infect (2006) 1.04
Aboriginal and non-Aboriginal health differentials in Australian prisoners. Aust N Z J Public Health (2007) 1.04
Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons. AIDS (2014) 1.03
A randomized controlled trial of the safety of candidate microbicide SPL7013 gel when applied to the penis. J Acquir Immune Defic Syndr (2009) 1.03
Establishing the Melbourne Injecting Drug User Cohort Study (MIX): rationale, methods, and baseline and twelve-month follow-up results. Harm Reduct J (2013) 1.02
In vitro fertilization and breast cancer: is there cause for concern? Fertil Steril (2012) 1.02
A randomized, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemia. AIDS (2002) 1.01
Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention. Addiction (2009) 1.01
Buffalo hump seen in HIV-associated lipodystrophy is associated with hyperinsulinemia but not dyslipidemia. J Acquir Immune Defic Syndr (2005) 1.01
In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk. Gynecol Oncol (2012) 1.00
Intensity of human prion disease surveillance predicts observed disease incidence. J Neurol Neurosurg Psychiatry (2013) 1.00
HBV or HCV coinfections and risk of myocardial infarction in HIV-infected individuals: the D:A:D Cohort Study. Antivir Ther (2010) 1.00
Mental health status of Aboriginal and non-Aboriginal Australian prisoners. Aust N Z J Psychiatry (2007) 0.99
Dendritic nanowire ultraviolet laser array. J Am Chem Soc (2003) 0.99
Dynamics of T cells and TCR excision circles differ after treatment of acute and chronic HIV infection. J Immunol (2002) 0.99
Characterizing HIV manifestations and treatment outcomes of perinatally infected adolescents in Asia. Pediatr Infect Dis J (2014) 0.99
The CpG island methylator phenotype is not associated with a personal or family history of cancer. Cancer Res (2004) 0.98
Are prisoners reliable survey respondents? A validation of self-reported traumatic brain injury (TBI) against hospital medical records. Brain Inj (2010) 0.98
Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study. BMC Infect Dis (2013) 0.98
Attitudes and beliefs towards methadone maintenance treatment among Australian prison health staff. Drug Alcohol Rev (2007) 0.97
Mortality among prisoners: how accurate is the Australian National Death Index? Aust N Z J Public Health (2005) 0.97
An objective lipodystrophy severity grading scale derived from the lipodystrophy case definition score. J Acquir Immune Defic Syndr (2003) 0.97
Is Western Australia representative of other Australian States and Territories in terms of key socio-demographic and health economic indicators? Aust Health Rev (2010) 0.96
Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database. PLoS One (2011) 0.96
Cancer incidence and mortality trends in Australian adolescents and young adults, 1982-2007. BMC Cancer (2012) 0.95
Rates and factors associated with major modifications to first-line combination antiretroviral therapy: results from the Asia-Pacific region. PLoS One (2013) 0.95
Eradicating syphilis, hepatitis C and HIV in MSM through frequent testing strategies. Curr Opin Infect Dis (2014) 0.95
Hormonal contraception is associated with a reduced risk of bacterial vaginosis: a systematic review and meta-analysis. PLoS One (2013) 0.94
Risk for retinal detachment after phacoemulsification: a whole-population study of cataract surgery outcomes. Arch Ophthalmol (2012) 0.94
Associations between immune depression and cardiovascular events in HIV infection. AIDS (2013) 0.94